Abstract
Adenosine is released from metabolically active cells by facilitated diffusion, and is generated extracellularly by degradation of released ATP. It is a potent biological mediator that modulates the activity of numerous cell types, including various neuronal populations, platelets, neutrophils and mast cells, and smooth muscle cells in bronchi and vasculature. Most of these effects help to protect cells and tissues during stress conditions such as ischaemia. Adenosine mediates its effects through four receptor subtypes: the A1, A2a, A2b and A3 receptors1. The A2a receptor (A2aR)2,3 is abundant in basal ganglia, vasculature and platelets, and stimulates adenylyl cyclase. It is a major target of caffeine, the most widely used psychoactive drug4. Here we investigate the role of the A2a receptor by disrupting the gene in mice. We found that A2aR-knockout (A2aR−/−) mice were viable and bred normally. Their exploratory activity was reduced, whereas caffeine, which normally stimulates exploratory behaviour, became a depressant of exploratory activity. Knockout animals scored higher in anxiety tests, and male mice were much more aggressive towards intruders. The response of A2aR−/−mice to acute pain stimuli was slower. Blood pressure and heart rate were increased, as well as platelet aggregation. The specific A2a agonist CGS 21680 lost its biological activity in all systems tested.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Olah, M. E. & Stiles, G. L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35, 581–606 (1995).
Libert, F. et al. Selective amplification and cloning of four new members of the G protein-coupled recptor family. Science 244, 569–572 (1989).
Maenhaut, C. et al. RDC8 codes for an adenosine A2receptor with physiological constitutive activity. Biochem. Biophys. Res. Commun. 173, 1169–1178 (1990).
Fredholm, B. B. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 76, 93–101 (1995).
Fink, J. S. et al. Molecular cloning of the rat A2adenosine receptor: selective co-expression with D2dopamine receptors in rat striatum. Mol. Brain. Res. 14, 186–195 (1992).
Furlong, T. J., Pierce, K. D., Selbie, L. A. & Shine, J. Molecular characterization of a human brain adenosine A2receptor. Mol. Brain Res. 15, 62–66 (1992).
Weaver, D. R. A2aadenosine receptor gene expression in developing rat brain. Mol. Brain Res. 20, 313–327 (1993).
Höpker, V. H., Saffrey, M. J. & Burnstock, G. The neuritogenic effect of myenteric plexus on striatal neurones in co-culture involves nitric oxide. Neuroreport 6, 1153–1156 (1995).
Schiffmann, S. N. & Vanderhaegheen, J. J. Adenosine A2receptors regulate the gene expression of striatopallidal and striatonigral neurons. J. Neurosci. 13, 1080–1087 (1993).
Balk, J. H. et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2receptors. Nature 377, 424–428 (1995).
Grace, A. A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1–24 (1991).
Nikodijeviç, O., Jacobson, K. A. & Daly, J. W. Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol. Biochem. Behav. 44, 199–216 (1993).
File, S. E., Baldwin, H. A., Johnston, A. L. & Wilks, L. J. Behavioral effects of acute and chronic administration of caffeine in the rat. Pharmacol. Biochem. Behav. 30, 809–815 (1988).
Jain, N., Kemp, N., Adeyemo, O., Buchanan, P. & Stone, T. W. Anxiolytic activity of adenosine receptor activation in mice. Br. J. Pharmacol. 116, 2127–2133 (1995).
Saudou, F. et al. Enhanced aggressive behavior in mice lacking 5-HT1Breceptor. Science 265, 1875–1878 (1994).
Palmour, R. M., Lipowski, C. J., Simon, C. K. & Ervin, F. R. Adenosine analogs inhibit fighting in isolated male mice. Life Sci. 44, 1293–1301 (1989).
Sawynok, J. & Yaksh, T. L. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol. Rev. 45, 43–85 (1993).
Sweeney, M. I., White, T. D., Jhamandas, K. H. & Sawynok, J. Morphine releases endogenous adenosine from the spinal cord in vivo. Eur. J. Pharmacol. 141, 169–170 (1987).
De Lander, G. E. & Keil, G. J. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice. J. Pharmacol. Exp. Ther. 268, 943–951 (1994).
McQueen, D. S. & Ribeiro, J. A. Pharmacological characterization of the receptor involved in chemoexcitation induced by adenosine. Br. J. Pharmacol. 88, 615–620 (1986).
Cristalli, G. et al. Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn. Schmiedebergs Arch. Pharmacol. 349, 644–650 (1994).
Dionisotti, S., Zocchi, C., Varani, K., Borea, P. A. & Ongini, E. Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity. Naunyn. Schmiedebergs Arch. Pharmacol. 346, 673–676 (1994).
Varani, K., Gessi, S., Dalpiaz, A. & Borea, P. A. Pharmacological and biochemical characterization of purified A2aadenosine receptors in human platelet membranes by [3H]-CGS 21680 binding. Br. J. Pharmacol. 117, 1693–1701 (1996).
Ongini, E. & Fredholm, B. B. Pharmacology of adenosine A2Areceptors. Trends Pharmacol. Sci. 17, 364–372 (1996).
Nagy, A., Rossant, J., Nagy, R., Abramow-Neverly, W. & Roder, J. C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl Acad. Sci. USA 90, 8424–8428 (1993).
Worst, W. & Joyner, A. L. in Gene Targeting, a Practical Approach (ed. Joyner, A. L.) 33–61 (Oxford University Press, Oxford, 1993).
Schiffmann, S. N. & Vanderhaegheen, J. J. Ontogeny of gene expression of adenosine A2receptor in the striatum: early localization in the patch compartment. J. Comp. Neurol. 317, 117–128 (1992).
Costentin, J. et al. Dissociated effects of inhibitors of enkephalin-metabolising peptidases or naloxone on various nociceptive responses. Eur. J. Pharmacol. 123, 37–44 (1986).
Acknowledgements
The R1 ES and STP cell lines were provided by A. Nagy and B. Colledge, respectively. We thank J.-F. Aubert for his help with the determination ofthe haemodynamic parameters; O. Le Moine, H. Louis, D. Penninck and C. Kucharzewski for discussion; and E. Bressy, M. J. Simons, E. Quertainmont and M. Verslype for technical assistance. This work was supported by the Belgian programme on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Federal Service for Science, Technology and Culture. It was also supported by the Fonds de la Recherche Scientifique Médicale of Belgium, the BIOMED2 programme, and the Foundation Médicale Reine Elisabeth. Scientific responsiblity belongs to the authors. C.L. and S.N.S. are Chercheurs Qualifiés of the Fonds National de la Recherche Scientifique.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ledent, C., Vaugeois, JM., Schiffmann, S. et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388, 674–678 (1997). https://doi.org/10.1038/41771
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/41771
This article is cited by
-
The role of adenosine receptor ligands on inflammatory pain: possible modulation of TRPV1 receptor function
Inflammopharmacology (2023)
-
In vivo phenotypic validation of adenosine receptor-dependent activity of non-adenosine drugs
Purinergic Signalling (2023)
-
Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models
Arthritis Research & Therapy (2022)
-
Locomotion activates PKA through dopamine and adenosine in striatal neurons
Nature (2022)
-
Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development
Molecular Diversity (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.